Recovery of tissue function following administration of B cells to injured tissue
US7695712B2 · kind B2 · utility
9Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2006 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Oct 1, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to systems and methods of enhancing recovery of function of injured tissue through administration of a composition comprising a relatively pure populations of B lymphocyte cells in a pharmaceutically acceptable carrier to the injured tissue. Kits are provided to aid in purification of B cells from heterogeneous mixtures of cells and administration of B cells to injured tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.